Product analysis: upon receipt at medtronic's quality laboratory, visual analysis revealed that the valve was discolored showing evidence of blood contact.Damage to the sewing ring between l2 and l3 was observed, which likely occurred during explant.All leaflets were in the closed position.All leaflets were flexible.All leaflets appeared intact.No leaflet damage observed.All commissures were intact.No commissure damage noted.Analysis showed that green markers on the sewing cuff did not properly align with the stent posts as is indicated in the manufacturing process.The outer diameter of the valve was measured and found acceptable per specification of this valve size and model.Conclusion: the device history record was reviewed and showed that this product met all manufacturing specifications for product released for distribution.No issues were identified that would have impacted this event.The sewing cuff was measured, and it is within the specification.The analysis confirmed that the sewing markers are not located at the mid sinus area of each cusp for this valve, which contributed to this event.If information is provided in the future, a supplemental report will be issued.
|
Medtronic received information that during the implant of this 23mm bioprosthetic valve, prior to insertion the physician noted the markers on the sewing cuff were not symmetrical and the sewing cuff appeared to be larger than expected.The physician continued to attempt to place the valve, however it would not pass through the sinotubular junction (stj).The valve was removed and an annular enlargement was performed.Sizing was repeated and a 21mm bioprosthetic valve was successfully implanted.No adverse patient effects were reported.
|